Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lung Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Liver Neoplasms 1Hypoxia 1Head and Neck Neoplasms 1

Interventions

PR-104 3apomine 2N-(4-(3-(1H-1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl)thiazol-2-yl)-2-amino-3-methylbutanamide 2tesetaxel 1ixabepilone 1intoplicine 1fluoromisonidazole 1eribulin 1bempegaldesleukin 1HhAntag691 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Docetaxel 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Unspecified Adult Solid Tumor, Protocol Specific × fluoromisonidazole × Clear all
NCT00616213 2011-06-01

PR104 and G-CSF in Treating Patients With Solid Tumors

Proacta, Incorporated

Phase 1 Completed
5 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡